First real-world study on the effectiveness and tolerability of rimegepant for acute migraine therapy in Chinese patients
{{output}}
Background: Rimegepant, a small molecule calcitonin gene-related peptide (CGRP) receptor antagonist, is indicated for acute and preventive migraine treatment in the United States and other countries. However, there is a lack of p... ...
